Modulation of intestinal TLR4 expression in infants with neonatal opioid withdrawal syndrome
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Modulation of intestinal TLR4 expression in infants with neonatal opioid withdrawal syndrome ; day:27 ; month:12 ; year:2023 ; pages:1-7
Journal of perinatology ; (27.12.2023), 1-7
- Urheber
-
Barnett, Rebecca C.
Lewis, Angela N.
Gong, Qingqing
Preston, Deborah L.
Frazer, Lauren C.
Werthammer, Joseph W.
Good, Misty
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41372-023-01859-2
- URN
-
urn:nbn:de:101:1-2024031113420495468240
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
2025-08-14T11:02:58+0200
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Barnett, Rebecca C.
- Lewis, Angela N.
- Gong, Qingqing
- Preston, Deborah L.
- Frazer, Lauren C.
- Werthammer, Joseph W.
- Good, Misty
- SpringerLink (Online service)
Ähnliche Objekte (12)
Abstinence scoring algorithms for treatment of neonatal opioid withdrawal syndrome (NOWS)
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study
Prediction of site-specific pharmacologic therapy among newborns with neonatal opioid withdrawal syndrome
Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS)
Increased risk of severe neonatal opioid withdrawal syndrome in pregnancies with low placental ABCB1 DNA methylation
Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study
The ultrasonic vocalization (USV) syllable profile during neonatal opioid withdrawal and a kappa opioid receptor component to increased USV emissions in female mice
Elucidating the context for implementing nonpharmacologic care for neonatal opioid withdrawal syndrome: a qualitative study of perinatal nurses
Single high-dose buprenorphine for opioid craving during withdrawal
The Role of Lofexidine in Management of Opioid Withdrawal
Atypical presentation of opioid withdrawal, an effect of adulteration
Abstinence scoring algorithms for treatment of neonatal opioid withdrawal syndrome (NOWS)
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study
Prediction of site-specific pharmacologic therapy among newborns with neonatal opioid withdrawal syndrome
Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS)
Increased risk of severe neonatal opioid withdrawal syndrome in pregnancies with low placental ABCB1 DNA methylation
Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study
The ultrasonic vocalization (USV) syllable profile during neonatal opioid withdrawal and a kappa opioid receptor component to increased USV emissions in female mice
Elucidating the context for implementing nonpharmacologic care for neonatal opioid withdrawal syndrome: a qualitative study of perinatal nurses
Single high-dose buprenorphine for opioid craving during withdrawal
The Role of Lofexidine in Management of Opioid Withdrawal
Atypical presentation of opioid withdrawal, an effect of adulteration
Abstinence scoring algorithms for treatment of neonatal opioid withdrawal syndrome (NOWS)
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study
Prediction of site-specific pharmacologic therapy among newborns with neonatal opioid withdrawal syndrome
Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS)
Increased risk of severe neonatal opioid withdrawal syndrome in pregnancies with low placental ABCB1 DNA methylation
Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study
The ultrasonic vocalization (USV) syllable profile during neonatal opioid withdrawal and a kappa opioid receptor component to increased USV emissions in female mice
Elucidating the context for implementing nonpharmacologic care for neonatal opioid withdrawal syndrome: a qualitative study of perinatal nurses
Single high-dose buprenorphine for opioid craving during withdrawal
The Role of Lofexidine in Management of Opioid Withdrawal